Mott MacDonald is the commercially appointed Management Agent for the Fleming Fund Country and Regional Grants and Fellowships programme. Their functions include leadership and coordination, grant scoping and administration, reporting, monitoring and risk management.
These are the organisations working with the Fleming Fund to halt the spread of antimicrobial resistance (AMR).
Global foundation which aims to harness advances in science and technology to save lives in developing countries. They work with partners to deliver proven tools, including vaccines, drugs and diagnostics, as well as discover path breaking solutions that are affordable and reliable. The Foundation is currently funding the Global Burden of Disease AMR project alongside the Fleming Fund and Wellcome Trust.
FAO is an agency of the United Nations who aims to achieve food security for all. The Fleming Fund supports the FAO to tackle AMR through a One Health approach alongside OIE and WHO, in 12 countries. The Fleming Fund also funds a secondee to support the delivery of the grant objectives and collaboration between the tripartite.
The University of Washington’s Institute for Health Metrics and Evaluation (IHME) and the University of Oxford’s Big Data Institute (BDI) are launching a new joint research unit whose aims are to collaborate and capitalise on tackling large-scale issues such as the Global Burden of Disease (GBD). The unit is currently implementing the GBD AMR project which is funded by the Fleming Fund, Wellcome Trust and Bill and Melinda Gates Foundation.
Itad provides independent, professional advice, monitoring and evaluation to organisations. Itad will conduct an independent evaluation of the Fleming Fund’s Country, Regional, and Fellowship Grant Programme. They will provide adaptive management support for Mott MacDonald enabling ongoing learning and programme improvement. Itad will also provide an evaluation of the Global Burden of Disease study.
The World organisation for Animal Health (OIE) is the intergovernmental organisation responsible for improving animal health worldwide. The Fleming Fund is supporting the OIE’s global work to tackle AMR through a One Health approach alongside FAO and WHO. The Fleming Fund has also funded a secondee to support the delivery of the grant objectives and close collaboration between the tripartite.
A Fleming Fund grant was awarded in 2015 to OUCRU, National Hospital for Tropical Diseases (NHTD), the University of Oxford, and Public Health England. The grant is supported by WHO and the Vietnamese Ministry of Health to establish a nationwide hospital-surveillance network and reference laboratory in Hanoi.
The South Centre, an international, multilateral organisation, is a key delivery partner for the Fleming Fund. It supports us by raising awareness of drug-resistance and advocating for action to address it among governments, civil society organisations and other networks in low- and middle-income countries.
The UK Collaborative on Development Research (UKCDR) has supported the Fleming Fund since its inception, notably organising a partner event in November 2017. This brought together all Fleming Fund delivery partners for the first time, and provided an opportunity for them to feed into new areas, such as the Fleming Fellowship Scheme.
Wellcome is exploring global solutions to tackle antimicrobial resistance, including funding new treatments, accelerating clinical trials, creating a global portfolio of open research and data, and working with Governments, industry and global health leaders to ensure concerted and coordinated action.
The WHO is the lead global agency on health. Their goal is to build a healthier future. The Fleming Fund supports the WHO to tackle AMR through a One Health approach alongside FAO and OIE in countries in Sub-Saharan Africa, South and South-East Asia . The Fleming Fund funds a secondee to support the delivery of the grant objectives and collaboration between the tripartite.